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Abstract
Background: It is now widely accepted that AMP-activated protein kinase (AMPK) is a critical regulator of energy
homeostasis. Recently, it has been shown to regulate circadian clocks. In seasonal breeding species such as sheep,
the circadian clock controls the secretion of an endogenous rhythm of melatonin and, as a consequence, is
probably involved in the generation of seasonal rhythms of reproduction. Considering this, we identified the
presence of the subunits of AMPK in different hypothalamic nuclei involved in the pre- and post-pineal pathways
that control seasonality of reproduction in the ewe and we investigated if the intracerebroventricular (i.c.v.)
injection of two activators of AMPK, metformin and AICAR, affected the circadian rhythm of melatonin in ewes that
were housed in constant darkness. In parallel the secretion of insulin was monitored as a peripheral metabolic
marker. We also investigated the effects of i.c.v. AICAR on the phosphorylation of AMPK and acetyl-CoA carboxylase
(ACC), a downstream target of AMPK, in brain structures along the photoneuroendocrine pathway to the pineal
gland.
Results: All the subunits of AMPK that we studied were identified in all brain areas that were dissected but with
some differences in their level of expression among structures. Metformin and AICAR both reduced (p < 0.001 and
p < 0.01 respectively) the amplitude of the circadian rhythm of melatonin secretion independently of insulin
secretion. The i.c.v. injection of AICAR only tended (p = 0.1) to increase the levels of phosphorylated AMPK in the
paraventricular nucleus but significantly increased the levels of phosphorylated ACC in the paraventricular nucleus
(p < 0.001) and in the pineal gland (p < 0.05).
Conclusions: Taken together, these results suggest a potential role for AMPK on the secretion of melatonin
probably acting trough the paraventricular nucleus and/or directly in the pineal gland. We conclude that AMPK
may act as a metabolic cue to modulate the rhythm of melatonin secretion.
Background
The serine-threonine kinase, AMPK integrates energy
homeostasis at both cellular [1] and whole-body levels
[2]. It exists as a heterotrimeric complex of a catalytic a
subunit and two regulatory b and g subunits. In mam-
mals there are two or three isoforms of each subunit
(a1, a2, b1, b2, g1, g2, g3), encoded by different genes,
allowing for a variety of heterotrimeric combinations
[3]. The treatment with pharmacological agents such as
metformin and 5-aminoimidazole-4-carboxamide-1-b-d-
ribofuranoside (AICAR) activates the AMPK complex
both in vitro and in vivo [4-6]. This mechanism is cen-
tral in the action of metformin when used as a insulin-
sensitizing agent to treat type II diabetes [7]. Recent
evidence points to an emerging role for AMPK as a cri-
tical element linking metabolism and reproduction [8].
Indeed, we demonstrated that treatment with either
metformin or AICAR significantly inhibited the release
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of GnRH from immortalised GnRH neurones (GT1-7
cells) and in vivo, it shortened the inter-oestrus interval
in mice [6]. In sheep as in all seasonal breeding species,
the daily rhythm of melatonin secretion is the critical
element mediating the synchronising effect of photoper-
iod on reproduction. This rhythm is endogenously con-
trolled by the activity of the master circadian pacemaker
located in the suprachiasmatic nucleus [9]. However,
how this endogenous rhythm of melatonin affects the
seasonal activity of the GnRH/LH/gonadal axis remains
unclear.
Um et al. [10] demonstrated that the peripheral activa-
tion of AMPK with metformin induced phase-shifts in
some of the core clock proteins thus suggesting a role for
AMPK in the control of circadian rhythms. In support of
these observations we have identified AMPK in the sheep
brain and we have tested, the effects of i.c.v. injections of
metformin or AICAR on the secretion of melatonin in
ewes housed in constant darkness. In parallel, because of
the functional interrelationships between melatonin and
insulin [11,12], we also monitored the secretion of insulin
as a potential metabolic marker of peripheral AMPK acti-
vation [13]. Our results suggest that i.c.v. injections of
metformin and AICAR both affect the amplitude of the
circadian rhythm of melatonin secretion without altering
the patterns of plasma insulin secretion.
Methods
Hormones and reagents
The metformin and AICAR used for the i.c.v. injections
were obtained from Sigma (Saint Quentin Fallavier,
France). The dose injected by means of an intracerebro-
ventricular catheter, was 128 mM for metformin (adapted
to sheep from [14]) and 12 mM for AICAR (similar to
[6]) in a total volume of 50 μl. Untreated control ewes
were injected with the same volume of an artificial cere-
brospinal fluid (CSF) solution, prepared in the laboratory.
All solutions had an equivalent osmolarity (≈ 305
mOsm).
Antibodies
Rabbit polyclonal antibodies to phospho-AMPKa
Thr172, AMPKa1/2, AMPKb1/b2, AMPKg2, phospho-
acetyl-CoA carboxylase (ACC) Ser79 and ACC were pur-
chased from New England Biolabs Inc. (Beverly, MA,
USA). A mouse monoclonal antibody to vinculin was
obtained from Sigma (Saint Quentin Fallavier, France)
and used as an internal standard.
Animals and experimental designs
Nineteen multiparous ewes were surgically fitted with
cannulae in the anterodorsal region of their third ventri-
cles [15]. Animals were housed in individual pens in a
light-sealed room under a lightning program mimicking a
long-day photoperiod (LP) (16 hours of light/day). All
ewes had free access to food, water and mineral licks.
In the first experiment, two groups of ewes (G1, G2, n
= 4) balanced for body condition score and live weight
were used in a cross-over design so that each group
received in random order 9 days apart (day 0 or D0 and
D10), either artificial CSF or metformin. Forty days
later, groups were re-balanced for their night-time
plasma concentrations of melatonin (G3, G4, n = 4),
and the experiment was repeated using AICAR with the
same cross-over design (D42 and D52) (Figure 1A). For
each i.c.v. injection, the ewes were fitted with an indwel-
ling catheter in the left jugular vein and housed in con-
stant darkness (DD) for one whole light/dark (L/D)
cycle. The ewes were bled every 60 min for 22 hrs, from
06:00 to 04:00 the next day, with a period of more
intensive blood sampling (every 20 min) around the
time of the i.c.v. injection at 19:00 (Figure 1B). Blood (3
ml) was collected into heparinised tubes and the plasma
was separated by centrifugation (3700 g, 20 min, 4°C)
and stored at -20°C.
For the second experiment, two groups of ewes
balanced as for experiment 1, were injected with either
AICAR (n = 6) or artificial CSF (n = 5). One hour after
injection the animals were slaughtered by decapitation,
the brain was removed quickly and frozen in isopentane
(SDS, Val De Rueil, France). The pituitary (PIT) and
pineal (PIN) glands were immediately dissected, frozen
in liquid nitrogen and stored at -80°C. Frontal sections
(1 mm thick) were sliced from the diencephalon and
other structures of interest were dissected using a sterile
scalpel, all were frozen in liquid nitrogen and stored at
-80°C. The hypothalamic structures of interest (supra-
chiasmatic nucleus [SCN], arcuate nucleus [ARC], med-
ian eminence [ME], paraventricular nucleus [PVN],
dorsomedial hypothalamic nucleus [DMH], tanycytes
[TAN] and premammilary hypothalamic nucleus
[PMH]) were identified using sheep brain atlases [16,17].
All these procedures were approved by the French
Agricultural and Scientific Research Agencies and con-
ducted in accordance with the EU guidelines for Care
and Use of Agricultural Animals in Agricultural
Research and Teaching.
Western-blotting
Western-blotting procedures were conducted as pre-
viously described [6] using 60 μg of protein per sample.
The data for the phosphorylation of AMPK and ACC
are expressed as the ratio of phosphorylated AMPK to
total AMPK and phosphorylated ACC to total ACC
respectively. The data for the AMPK subunits have been
normalised against an internal standard (vinculin).
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Assays
Melatonin was assayed using a radioimmunoassay (RIA)
described by Fraser et al. [18], with an antibody raised
by Tillet et al. [19]. The assay sensitivity was 4 pg/mL,
the intra-assay coefficient of variation (CV) ranged
between 9-14% and the inter-assay CV was 12%. Insulin
was also assayed using a RIA that was developed in our
laboratory. Plasma concentrations of insulin were deter-
mined in duplicate 100 μL samples. The assay buffer
was 0.025 M barbital buffer containing 3% bovine serum
albumin (Sigma, Saint Quentin Fallavier, France). Plasma
samples were incubated (24 hrs at 4°C) with 300 μL of
the primary antibody (anti-porcine insulin antibody
raised in guinea pig, final dilution 1/80000; Sigma, Saint
Quentin Fallavier, France) added with 0.6 μL of Triton
X-100 and 0.5 μL of normal rabbit serum. Samples were
then incubated (24 hrs) with 20,000 cpm of iodinated
porcine insulin. The next day, samples were incubated
for 48 hrs at 4°C with 2 mL of the secondary antibody
(anti-guinea pig IgG raised in horses, final dilution
1/333), 4 g/L of CaCl2 and 30 g/L of polyethylene glycol.
Tubes were then centrifuged (3,000 g for 30 min at 4°C),
the supernatant was removed, and the radioactivity in
the precipitate was counted with a Wallac Wizard
gamma counter (PerkinElmer Inc., Waltham, Massachu-
setts, USA) for 1 min. The sensitivity of the assay was
0.95 ± 0.06 ng/mL and the intra-assay CV was 12%.
Data and Statistical analysis
Melatonin profiles were analysed by comparing the tim-
ing of resumption and the amplitude, of the circadian
rhythm of melatonin secretion. These criteria were
determined using the method of Malpaux et al. [20].
Statistical analyses were performed using the statistical
software package, R [21]. Data for insulin were analysed
using a mixed-effects model and other data, after log
transformation for normalization, were analysed using
an analysis of variance. All results are presented as
means ± sem. Differences were considered statistically
significant whenever p < 0.05.
Results
The amplitude of the endogenous rhythm of melatonin
was reduced significantly by both metformin (p < 0.001)
and AICAR (p < 0.01) (Figure 2) but the timing of
resumption was not affected by either (data not shown).
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Figure 1 Experimental design for the first experiment. (A) Schematic representation of the cross-over experimental design. Photoperiodic
treatments are given in the upper part. 3 weeks before the first day of injection (D0) the ewes were housed under LP. During each day of
injection (D0 and D10 for metformin; D42 and D52 for AICAR) LP was replaced by DD. (B) Bleeding protocol operated during DD, each thick
depicts one sample. Thick arrow depict the clock time for the administration of the injection (19:00). Serial sampling period began 1 hr before
injection and lasted for 7 hrs (from 17:00 to 00:00 during the injection of metformin and adjusted from 18:00 to 01:00 for the injection of AICAR).
Thin arrows depict theoretical lightning transitions. See text for more details.
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After each i.c.v. injection of metformin at D0 and D10
(Figure 2A), the amplitude of the endogenous rhythm of
melatonin was reduced when compared to controls (p <
0.001). This was also the case between D0 and D10 for
the ewes in G1 (p < 0.001), that is those ewes injected
first with the vehicle solution, but not for the ewes in
G2 that is those ewes injected first with metformin.
After injection of AICAR (Figure 2B), the amplitude of
the endogenous rhythm of melatonin was reduced at
D42 compared to controls (p < 0.001) but not at D52.
However, when compared between D42 and D52, the
amplitude of the endogenous rhythm of melatonin was
consistently reduced after the injection of AICAR in
both groups (p < 0.05). There was no significant effect
of metformin or AICAR on the concentrations of insulin
(Figure 3).
The results of experiment 2 show that the expression
levels of the AMPK subunits (Figure 4) were different
among hypothalamic structures. The expression of the
b2 subunit was lower in the PMH/PIN when compared
to the PVN/SCN (p < 0.05) and the expression of the g2
subunit was lower in the PMH when compared to the
PVN/SCN/TAN (p < 0.05). After i.c.v. injection of
AICAR, the phosphorylation rate of AMPK tended (p =
0.1) to be higher only in the PVN (Figure 5A) but the
phosphorylation rate of ACC at Ser79 was significantly
higher in both the PVN (p < 0.001) and PIN (p < 0.05)
(Figure 5B).
Discussion
The hypothesis tested in this study, developed from the
findings of Um et al. [10], was that central activation of
AMPK could disrupt the circadian machinery located in
the SCN and thus, alter the endogenous timing of the
resumption of melatonin secretion by the pineal gland.
In our study, such an effect was not observed after i.c.v.
treatment with metformin or AICAR, both known acti-
vators of AMPK. Surprisingly we found that another
component of the endogenous rhythm of melatonin, its
amplitude, was altered by these compounds.
There are three main possibilities to account for the
rejection of our hypothesis. First, the i.c.v. treatment with
either metformin or AICAR was ineffective and did not
stimulate AMPK in the hypothalamic structures we
Figure 2 The monitoring of the endogenous rhythm of secretion of melatonin. The data show the concentration of plasma melatonin for
each group separately (G1 to G4). Animals were housed in constant darkness and given an i.c.v. injection of either metformin (G1 & G2; open
triangle) or AICAR (G3 & G4; open square) or artificial CSF as a control vehicle (closed circle). Injections were performed nine days apart and in a
random order for each group (see text and Figure 1 for more details about the order of injection for each group). The arrows depict the time of
injection and shaded area corresponds to the period of increased sampling frequency. Note the log-scale y-axis.
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Figure 3 The monitoring of the secretion of plasma insulin. The data show the concentration of plasma insulin in two groups of ewes
housed in constant darkness and given an i.c.v. injection of either (A) metformin or (B) AICAR (open circle) or a synthetic CSF as a control
vehicle (closed circle). The arrows depict the time of injection.
Figure 4 Western-blotting quantification of the AMPK subunits a, b1, b2 and g2 in pituitary gland (PIT), median eminence (ME),
arcuate nucleus (ARC), dorsomedial and premammilary hypothalamus (DMH, PMH), tanycytes (TAN), pineal gland (PIN) and
paraventricular and suprachiasmatic nuclei (PVN, SCN) of the sheep brain. Different letters indicate a stastistically significant difference (p <
0.05).
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examined. Indeed, the similarities of the effects between
the i.c.v. injections of both drugs on the amplitude of the
rhythm of melatonin secretion suggest that they might be
mediated by the activation of AMPK, as a common ele-
ment along their distinct signalling pathways [22]. How-
ever, we do not exclude possible AMPK-independent
effects [23]. Second, the treatment effectively activated
AMPK within the SCN, but in DD when the SCN is
released from entrainment by the prevailing LP produced
conflicting signals because of the persistence of entrain-
ment by the preceding LP [24] and the expected
SCN-driven phase shift in the resumption of melatonin
secretion. Third, the treatment effectively activated
AMPK but not within the SCN or without triggering
phase-shifts in the master circadian machinery perhaps
because of functional differences [25] between the master
circadian clock and the peripheral-slaves clock that was
studied by Um et al. [10].
The biological relevance of the lowering effects of both
metformin and AICAR on the amplitude of the endogen-
ous rhythm of melatonin is difficult to interpret. Indeed,
in sheep as in most photoperiodic species, the duration of
melatonin secretion is the critical feature of the rhythm of
melatonin secretion that transmits photoperiodic informa-
tion to the reproductive axis [26]; the role played by the
amplitude, the other main feature of this rhythm, remains
controversial [27-29]. Some authors have suggested that
the amplitude of the melatonin rhythm acts as a potent
integrator of environmental factors, other than photoper-
iod for example, temperature and the food supply (for
review see [30]). In relation to this theory, a complemen-
tary study (Menassol et al., unpublished data) has estab-
lished that feed restriction can alter the seasonal
reproductive patterns of the Île-de-France ewe as has been
reported in a previous study on sheep [31], and that this
alteration is associated with lower concentrations of
plasma melatonin. Therefore we speculate that the central
activation of AMPK is involved in the integration of meta-
bolic-related cues that alter the amplitude of the rhythm
of melatonin secretion. We speculate further that this
effect is mediated by neuropeptides or peptidergic hor-
mones that regulate the amplitude of the rhythm of mela-
tonin secretion such as Vasoactive Intestinal Peptide
(VIP), Pituitary Adenylate Cyclase Activating Peptide
(PACAP) or Vasopressin (VP) (for review see [32]) and
particularly Neuropeptide Y (NPY) which is activated by
AMPK [33].
The effect of metformin and AICAR on the amplitude
of the rhythm of melatonin secretion was not associated
with immediate changes in insulin secretion and thus,
was not attributable to the interrelationship that exists
between these two hormones [11,12,34]. Interestingly,
some studies have reported a decrease in melatonin con-
centrations associated with the development of diabetes
[35,36]. Thus, assuming that metformin crosses the
blood-brain barrier, one can ask if therapeutic treatment
with metformin could not have unreported side-effects
on the secretion of melatonin.
The characterization of the expression of AMPK within
the hypothalamus, pituitary and pineal glands of the ewes
suggests a potentially wide range of action for metformin
and AICAR since all subunits were identified in each of
the structures that we examined. The differences among
structures in the level of expression of the b2 and g2 sub-
units may indicate structural specificities in the sensitivity
or functionality of the AMPK complex [2]. Indeed, our
investigation of the potential central sites of actions of
the AMPK complex, point preferentially to the PVN as a
Figure 5 Western-blotting quantification of the phosphorylation rate of AMPK and ACC after i.c.v. injection of AICAR. (A) The ratio of
phosphorylated AMPK at Thr172 to total AMPK following an i.c.v. injection of a synthetic CSF vehicle or AICAR. (B) The ratio of phosphorylated
ACC at Ser79 to total ACC following an i.c.v. injection of a synthetic CSF vehicle or AICAR.
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structure of particular interest because some of its neu-
rons that express melatonin-regulating peptides project
to the pineal gland [32]. In this particular structure, the
direct assessment of the phosphorylation rate of AMPK
only reveals a trend toward significance (p = 0.1) for a
greater activation after i.c.v. injection of AICAR. However
the indirect measurement of AMPK activity, trough the
assessment of the phosphorylation rate of its downstream
target ACC [37,38], shows that AICAR treatment signifi-
cantly inhibited ACC activity in both the paraventricular
nucleus (p < 0.001) and the pineal gland (p < 0.05).
Therefore the PVN is strongly suggested as a key struc-
ture that mediates metabolic influences on the rhythm of
secretion of melatonin. Moreover, it seems that direct
effects of AMPK on the pineal gland activity itself can
not be excluded.
In this experiment, the failure to demonstrate signifi-
cant direct activation of the AMPK complex following
treatment with AICAR might be explained by the time
elapsed between tissue fixation and injection (1 hr) and
the possible action of endogenous phosphatases [39].
Conclusion
To conclude, the i.c.v. administration of AMPK-activators
had an unexpected insulin-independent effect on the
amplitude of the endogenous rhythm of secretion of mela-
tonin that retrospectively, might have also been observed
in natural photoperiodic conditions, on the daily pattern
of melatonin secretion. This effect probably involves the
AMPK system trough the paraventricular nucleus and/or
directly within the pineal gland. This mechanism remains
to be precisely determined but we suggest that it involves
the integration of metabolic-related cues with the photo-
periodic signal that synchronizes the annual rhythm of
reproduction in sheep.
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